ArticleEMBO molecular medicine2024

MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.

Ruina Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.